Once-Daily Dosing vs. Conventional Dosing Schedule of Mesalamine and Relapse of Quiescent Ulcerative Colitis: Systematic Review and Meta-Analysis

An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease

(2011) Nicholas J Talley et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Once daily Asacol

(2011) A. B. Hawthorne et al.   GUT

Review article: understanding adherence to medication in ulcerative colitis - innovative thinking and evolving concepts

(2010) S. V. Kane et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trial

(2010) G. R. Lichtenstein et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis

(2010) W. Kruis et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis

(2010) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative Colitis

(2010) William J. Sandborn et al.   GASTROENTEROLOGY

Once daily versus conventional dosing of pH-dependent mesalamine long-term to maintain quiescent ulcerative colitis: Preliminary results from a randomized trial

(2010) Sunanda Kane   Patient Preference and Adherence

Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX®with Asacol®

(2009) C. PRANTERA et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis

(2009) Axel U. Dignass et al.   Clinical Gastroenterology and Hepatology

Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares

(2008) P. D. R. HIGGINS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

(2008) M A Kamm et al.   GUT